Cargando…
Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
BACKGROUND: The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. PATIENTS AND METHO...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314582/ https://www.ncbi.nlm.nih.gov/pubmed/34315423 http://dx.doi.org/10.1186/s12885-021-08610-0 |
_version_ | 1783729580832456704 |
---|---|
author | Yang, Shan-Shan Chen, Lei Liu, Ying Lu, Hai-Jun Huang, Bo-Jie Lin, Ai-Hua Sun, Ying Ma, Jun Xie, Fang-Yun Mao, Yan-Ping |
author_facet | Yang, Shan-Shan Chen, Lei Liu, Ying Lu, Hai-Jun Huang, Bo-Jie Lin, Ai-Hua Sun, Ying Ma, Jun Xie, Fang-Yun Mao, Yan-Ping |
author_sort | Yang, Shan-Shan |
collection | PubMed |
description | BACKGROUND: The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. PATIENTS AND METHODS: A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson’s correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach’s ɑ, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs). RESULTS: Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach’s ɑ of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71–0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness. CONCLUSION: The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08610-0. |
format | Online Article Text |
id | pubmed-8314582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-83145822021-07-28 Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events Yang, Shan-Shan Chen, Lei Liu, Ying Lu, Hai-Jun Huang, Bo-Jie Lin, Ai-Hua Sun, Ying Ma, Jun Xie, Fang-Yun Mao, Yan-Ping BMC Cancer Research BACKGROUND: The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. PATIENTS AND METHODS: A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson’s correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach’s ɑ, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs). RESULTS: Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach’s ɑ of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71–0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness. CONCLUSION: The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08610-0. BioMed Central 2021-07-27 /pmc/articles/PMC8314582/ /pubmed/34315423 http://dx.doi.org/10.1186/s12885-021-08610-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Yang, Shan-Shan Chen, Lei Liu, Ying Lu, Hai-Jun Huang, Bo-Jie Lin, Ai-Hua Sun, Ying Ma, Jun Xie, Fang-Yun Mao, Yan-Ping Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events |
title | Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events |
title_full | Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events |
title_fullStr | Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events |
title_full_unstemmed | Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events |
title_short | Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events |
title_sort | validity and reliability of the simplified chinese patient-reported outcomes version of the common terminology criteria for adverse events |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314582/ https://www.ncbi.nlm.nih.gov/pubmed/34315423 http://dx.doi.org/10.1186/s12885-021-08610-0 |
work_keys_str_mv | AT yangshanshan validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents AT chenlei validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents AT liuying validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents AT luhaijun validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents AT huangbojie validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents AT linaihua validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents AT sunying validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents AT majun validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents AT xiefangyun validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents AT maoyanping validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents |